# Nexgenia Inc.: Form D filings

Nexgenia Inc., a biotechnology company in Seattle, WA, filed 5 Form D notices with the SEC between 2014 and 2018. The latest, on May 15, 2018, reports $119,099 sold of a $250,000 offering to 14 investors.

Find out what Nexgenia Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Nexgenia%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Nexgenia%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnexgenia-inc-1623317)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Nexgenia%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Nexgenia%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnexgenia-inc-1623317)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 454 NORTH 34TH ST., SUITE LL, Seattle, WA, 98103
- Phone: (206) 290-8902
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1623317

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 15, 2018 | New notice | $250,000 | $119,099 | $130,901 | 14 | May 8, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1623317/000162331718000001/0001623317-18-000001-index.htm) |
| Apr 5, 2017 | New notice | $1,900 | $0 | $1,900 | 1 | Mar 23, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1623317/000116840417000006/0001168404-17-000006-index.htm) |
| Aug 19, 2016 | New notice | $2,000,000 | $1,859,887 | $140,113 | 15 | Aug 5, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1623317/000116840416000036/0001168404-16-000036-index.htm) |
| Jun 29, 2015 | New notice | $3,547,583 | $1,617,582 | $1,930,001 | 9 | Jun 17, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1623317/000162331715000001/0001623317-15-000001-index.htm) |
| Oct 28, 2014 | New notice | $1,000,000 | $500,000 | $500,000 | 2 | Oct 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1623317/000162331714000001/0001623317-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Steven Gillis | Director |  |
| Stewart Parker | Director |  |
| Ron Myers | Executive Officer, Director |  |
| David Urdal | Director |  |
| Martin Simonetti | Director |  |
| Charles P. Waite | Director |  |

## Other biotechnology companies in Washington that filed recently

- [Key Proteo, Inc.](https://specstream.ai/data/form-d/company/key-proteo-inc-1977784) $2.3 million · Oct 23, 2026
- [Inmedix, Inc.](https://specstream.ai/data/form-d/company/inmedix-inc-1851853) $4 million · Oct 22, 2026
- [Q-Immune, Inc.](https://specstream.ai/data/form-d/company/q-immune-inc-2155816) $25,000 · Sep 28, 2026
- [Hexamer Therapeutics, Inc](https://specstream.ai/data/form-d/company/hexamer-therapeutics-inc-1797915) $500,000 · Sep 15, 2026
- [MalarVx, Inc.](https://specstream.ai/data/form-d/company/malarvx-inc-1559688) $125,000 · Aug 25, 2026
- [Strella Biotechnology, Inc.](https://specstream.ai/data/form-d/company/strella-biotechnology-inc-1810011) $1.8 million · Aug 14, 2026

[Every Form D from the week of May 14, 2018](https://specstream.ai/data/form-d/week/2018-05-14) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Nexgenia Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).